News release

Watch ChemoMetec – FY 2022/23 webcast

We released the FY 2022/23 Annual Report of ChemoMetec A/S on September 13, 2023. A conference call took place on September 14th.

During the call, CEO Rasmus Kofoed and CFO Niels Høy Nielsen presented the Annual Report 2022/23. The presentation was followed by a Q&A session.

The conference call was conducted in English and you can watch or re-watch the conference call below.

If you only want to see the investor presentation, you can download the PDF here: Investor Presentation PDF

Annual repport

The webcast is now available on-demand or listen to the podcast below.


Rasmus Kofoed

Niels Høy Nielsen
(+45) 2551 8724

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson. ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For more information, go to

Sign Up for Investor News